Skip Navigation

Early Drug Development Center Team

  • The Early Drug Development Center (EDDC) treatment team is comprised of a multidisciplinary group of medical oncologists, cardiologists, nephrologists, nursing staff and researchers who specialize in designing, conducting and analyzing clinical trials of experimental medicines to ensure that your treatment is closely monitored and safe. In addition, the EDDC targets disease-specific malignancies by collaborating with Dana-Farber clinicians across all treatment centers who are dedicated to improving your care with their expertise.

    Early Drug Development Center Clinicians

    Geoffrey Shapiro, MD, PhD, Disease Center Leader
    Khanh Do, MD, Clinical Director
    Andrew Wolanski, NP

    Disease Center Collaborators

    Elizabeth Buchbinder, MD, Melanoma Cancer Treatment Center
    Atish Choudhury, MD, PhD, Genitourinary Treatment Center
    James Cleary, MD, PhD, Gastrointestinal Cancer Treatment Center
    Rinath Jeselsohn, MD, Breast Cancer Treatment Center
    Sara Tolaney, MD, Breast Cancer Treatment Center

    Research Nurses

    Anne Caramella, RN, BSN
    Jennifer Hedglin, RN, BSN
    Danielle Nunziato, RN, BSN
    Rachel Patchel, RN, BSN
    Allison Powers, RN, BSN
    Nicholas Quinn, RN, BSN

    Clinical Research Manager

    Ketki Bhushan, MPH

    Regulatory Coordinators

    Elizabeth Downey
    Solida Pruitt-Thompson
    Allison Valencia

    Senior Clinical Research Coordinators

    Illy Dixon
    Matt Milstein

    Clinical Research Coordinators

    Philip Chieng
    Sarah Desmarais
    Courtney Gannon
    Sienna Kardel
    Sarah Kelland
    Loan Vuong